Dr. Barry Dworkin

Paxil interferes with tamoxifen's efficacy combating breast cancer/Sunday House Call returns to the airwaves

Madely Health Headlines Commentary for February 10, 2010

[display_podcast]

Source:

Paxil, Tamoxifen May Be a Risky Combo

Reference:

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

Related posts:

  1. Breast cancer risk from hormone replacement needs perspective when compared to other contributing factors
  2. Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
  3. Tamoxifen shown to reduce breast cancer recurrence for women with early stage disease
  4. Prescription drugs and herbal remedies follow the same science of drug interactions and can negatively affect health outcomes

Leave a Reply